Screen LibraryStudies on Competition and Antitrust Issues in the Pharmaceutical Industry /
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-d...
Saved in:
| Main Authors: | |
|---|---|
| Corporate Authors: | |
| Published: |
Springer Fachmedien Wiesbaden : Imprint: Springer Gabler,
|
| Publisher Address: | Wiesbaden : |
| Publication Dates: | 2017. |
| Literature type: | eBook |
| Language: | English |
| Series: |
BestMasters
|
| Subjects: | |
| Online Access: |
http://dx.doi.org/10.1007/978-3-658-16551-2 |
| Summary: |
This publication examines how drug originator manufacturers manage to shield their products from competition. It characterizes the pharmaceutical industry in detail and analyzes actions that violate antitrust laws in the USA and/or the European Union. The publication examines, for example, pay-for-delay strategies, market foreclosure, resale price maintenance, but also mergers and acquisitions, while taking into account market specificities such as the unique research and development process. The study explains why drug prices sometimes remain at elevated levels even after the drug s patent |
| Carrier Form: | 1 online resource (XIV, 85 pages): illustrations. |
| ISBN: | 9783658165512 |
| Index Number: | HD28 |
| CLC: | F403.6 |
| Contents: | Overview of Antitrust and Competition Issues -- Vertical Restraints under Parallel Trade -- Competitive Restraints under Reference Pricing. |